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Diagnosing Ocular Surface Squamous
Neoplasia in East Africa
Case-Control Study of Clinical and In Vivo Confocal
Microscopy Assessment
Marie B. Nguena, MMed,1 Jan G. van den Tweel, MD, PhD,2 William Makupa, MMed,1
Victor H. Hu, PhD, MRCOphth,1,3 Helen A. Weiss, MSc, PhD,4 Stephen Gichuhi, MBChB, MMed,3,5
Matthew J. Burton, PhD, FRCOphth1,3
Objective: To examine the reliability of clinical examination and in vivo confocal microscopy (IVCM) in dis-
tinguishing ocular surface squamous neoplasia (OSSN) from benign conjunctival lesions.
Design: Case-control study.
Participants: Sixty individuals with conjunctival lesions (OSSN and benign) and 60 age-matched controls
with normal conjunctiva presenting to Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Methods: Participants were examined and photographed, and IVCM was performed. Patients with
conjunctival lesions were offered excisional biopsy with histopathology and a human immunodeﬁciency virus
(HIV) test. The IVCM images were read masked to the clinical appearance and pathology results. Images were
graded for several speciﬁc features and given an overall categorization (normal, benign, or malignant). A group of
8 ophthalmologists were shown photographs of conjunctival lesions and asked to independently classify as
OSSN or benign.
Main Outcome Measures: Comparison of the histopathology diagnosis with the clinical and IVCM
diagnosis.
Results: Fifty-two cases underwent excisional biopsy with histopathology; 34 were on the OSSN spectrum,
17 were benign, and 1 was lymphoma. The cases and controls had comparable demographic proﬁles. Human
immunodeﬁciency syndrome infection was more common in OSSN compared with benign cases (58.8% vs.
5.6%; odds ratio, 24.3, 95% conﬁdence interval [CI], 2.8e204; P ¼ 0.003). Clinically, OSSN lesions more
frequently exhibited feeder vessels and tended to have more leukoplakia and a gelatinous appearance. Overall,
the ophthalmologists showed moderate agreement with the histology result (average kappa ¼ 0.51; 95% CI,
0.36e0.64). The masked grading of IVCM images reliably distinguished normal conjunctiva. However, IVCM was
unable to reliably distinguish between benign lesions and OSSN because of an overlap in their appearance
(kappa ¼ 0.44; 95% CI, 0.32e0.57). No single feature was signiﬁcantly more frequent in OSSN compared with
benign lesions. The sensitivity and speciﬁcity of IVCM for distinguishing OSSN from benign conjunctival lesions
were 38.5% and 66.7%, respectively.
Conclusions: In East Africa, conjunctival pathology is relatively common and can present signiﬁcant diag-
nostic challenges for the clinician. In this study, neither clinical examination nor IVCM was found to reliably
distinguish OSSN from benign conjunctival pathology because of an overlap in the features of these groups.
Therefore, IVCM cannot currently replace histopathology, and management decisions should continue to rely on
careful clinical assessment supported by histopathology as indicated. Ophthalmology 2014;121:484-491 ª 2014
by the American Academy of Ophthalmology.
Ocular surface squamous neoplasia (OSSN) is the most
common malignant ocular surface disease in Africa.1e3 It
ranges from small areas of conjunctiva intra-epithelial
neoplasia (CIN) to large invasive squamous cell carcinoma
(SCC).4 There has been a marked increase in the incidence
of this disease in East Africa over the last couple of decades,
attributed to human immunodeﬁciency virus (HIV)/
AIDS.3,5e7 The disease now presents at a younger age
than previously and affects more women than men.
Although HIV positivity is a well-deﬁned major risk factor
for OSSN, approximately half of all cases in East Africa are
HIV positive and the role of other etiologic factors needs to
be deﬁned.4,7 Data from case-control studies suggest that
damage from ultraviolet light exposure in equatorial regions
may be important.7 Human papilloma virus has been
postulated to be involved, but its contribution remains
uncertain despite several studies.8
One of the challenges facing clinicians managing OSSN
is distinguishing early neoplastic from benign lesions
(Fig 1A, B). This is a particular problem in East Africa,
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where benign conjunctival changes (pterygium, pingeculum)
are relatively common. There is probably an overlap in
the clinical features of these different benign lesions
and OSSN, with no signs being exclusive to OSSN,
although this has not been formally evaluated. Some
features have been reported to be more common in
advanced cases of OSSN.4 Histopathology is necessary
to conﬁrm a diagnosis of OSSN. However, pathology
services are generally scarce in East Africa outside larger
centers. As a result, many lesions are excised without
pathologic analysis.
The standard approach for treating suspected OSSN is an
excisional biopsy, often with cryotherapy to the conjunctival
margin and sometimes with topical chemotherapy.9,10 An
initial incisional biopsy is usually performed for larger
lesions to make a diagnosis to plan treatment. In recent
years, there has been a move to consider primary topical
chemotherapy for suspected OSSN without a tissue
Figure 1. Photographs of a pterygium and various grades of ocular surface squamous neoplasia: pterygium (A), conjunctiva intra-epithelial neoplasia (CIN)
1 (B), CIN 3 (C), carcinoma in situ (D), squamous cell carcinoma (SCC) grade 1 (E), SCC grade 2 (F), SCC grade 3 (G), and SCC with orbital invasion
(H).
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diagnosis.11 Given the potential uncertainty of diagnosis
based on clinical signs alone, several groups have
investigated whether in vivo confocal microscopy (IVCM)
can help distinguish cases of OSSN.12e16 These reports of
relatively few cases (26 in the whole literature) have tended
to conclude that IVCM may be helpful in making a diag-
nosis of OSSN. Several speciﬁc features, such as irregular
cell size, hyper-reﬂectivity, prominent bright nucleoli
(“starry night appearance”), and mitotic ﬁgures, have been
singled out as potential markers for OSSN.13
We report a prospective study of patients with conjunc-
tival lesions presenting to an ophthalmic unit in Tanzania.
We investigate the diagnostic accuracy of the clinical
examination and whether certain features help to distinguish
OSSN from benign lesions. Second, we evaluate the utility
of IVCM in identifying OSSN in a masked study of
conjunctival lesions.
Methods
Ethical Approval
This study adhered to the tenets of the Declaration of Helsinki. It
was reviewed and approved by the Kilimanjaro Christian Medical
Centre (KCMC) Ethics Committee, Tanzania.
Study Design and Participants
In this case-control study, we compared individuals with
conjunctival lesions (“cases,” either benign or OSSN) with indi-
viduals with clinically normal conjunctiva (“controls”). Recruit-
ment of both cases and controls was conducted at the Department
of Ophthalmology, KCMC Hospital, Moshi, Tanzania, from May
to November 2011. Cases were consecutive individuals presenting
with a conjunctival lesion that on clinical grounds required surgical
excision. For each case, we recruited a control presenting for
a condition that was not affecting the ocular surface and who had
healthy conjunctiva on slit-lamp examination (e.g., cataract). These
control participants were age-matched to the corresponding case
(5 years). All participants were aged 18 years or older. The study
was explained to eligible study subjects, and written informed
consent was obtained before enrollment. All enrolled patients with
conjunctival lesions received counseling and were offered testing
for HIV, which is standard of care at KCMC. Patients with
a positive HIV test result were referred to the Comprehensive
Treatment Center.
Clinical Assessment
Patients with conjunctival lesions were asked about symptoms
(ocular pain, irritation, itchiness, redness, decreased vision, prop-
tosis, and discharge). Participants were asked where they lived
within Tanzania and their main occupation. The surface of the eye
was carefully examined with a slit lamp for conjunctival
pathology. We recorded lesion location and size and the presence
of speciﬁc features, including ﬁbrovascular tissue (Fig 1A, B),
leukoplakia (Fig 1C), gelatinous appearance (Fig 1D), feeder
vessels (Fig 1D), papilliform structure (Fig 1F), limbal
involvement, and orbital invasion (Fig 1H). The lesions were
photographed using a digital single lens reﬂex camera with
a macro lens.
In Vivo Confocal Microscopy Examination
In vivo confocal microscopy examination of the bulbar conjunctiva
was performed using the Heidelberg Retina Tomograph 3 in
combination with the Rostock Corneal Module (Heidelberg Engi-
neering GmbH, Dossenheim, Germany). A sterile, disposable
polymethylmethacrylate cap was mounted on the head of the
confocal microscope, and a drop of topical anesthetic (proparacaine
0.5%) was instilled into the inferior fornix of the eye before the
examination. For cases, the lesion and surrounding areas were
scanned. For controls, the temporal or nasal inter-palpebral
conjunctiva was scanned. Representative images of the examined
conjunctiva were obtained using the “volume scan” mode, which
collects a series of 40 parallel images 2 mm apart; both surface
(starting at the epithelium) and deeper sets of scans were
performed.
All confocal images were graded over a 2-day period, after
recruitment had been completed. Two ophthalmologists (M.B.N.,
M.J.B.) jointly examined all the images; they were masked to the
case/control status, clinical features, and histopathology results.
The grading of the images was based on separately examining each
of the 40 parallel images in each of the volume scan stacks. The
following features, which are said to be potentially discriminating
in previous studies, were evaluated: variable epithelial cell size,
hyperreﬂectivity, presence of mitotic cells, and prominent bright
nucleoli (“starry night appearance”) (Fig 2).13 An overall
provisional categorization based on the IVCM ﬁndings was
made: (1) normal, (2) abnormal benign, or (3) abnormal malignant.
Surgical Treatment
Lesions were treated surgically. Small to medium-sized lesions that
were clinically suspicious for OSSN were fully excised using the
“no touch technique” with a 3- to 4-mm margin of healthy-looking
tissue. Surgical sponges saturated with 5-ﬂuorouracil were applied
to the excision site for 5 minutes followed by irrigation with normal
saline. 5-Fluorouracil treatment was not used if the case was thought
to be benign pathology, such as a pterygium. Incisional biopsies
were performed for large lesions to obtain tissue for histology
assessment. If malignant pathology was conﬁrmed, radical surgery
(enucleation or exenteration) was then offered to the patient. Biopsy
tissue was not collected from the normal controls.
Histopathology
Biopsy specimens from the cases were immediately placed in 10%
formaldehyde solution. These were mounted in parafﬁn wax, and
5-mm sections were cut perpendicular to the conjunctival surface
and stained with hematoxylineeosin. All specimens were exam-
ined by a single pathologist (J.G.T.). Ocular surface squamous
neoplasia was classiﬁed using the standard deﬁnitions for mild
(CIN I), moderate (CIN II), and severe (CIN III) dysplasia, carci-
noma in situ, and invasive SCC.17 Squamous cell carcinoma was
subdivided by the degree of differentiation: well (I), moderate
(II), and poor (III).
Clinical Diagnosis Study
To evaluate the ability of clinicians to correctly distinguish
between benign and malignant conjunctival lesions, we showed
a group of 8 ophthalmologists (3 consultants and 5 residents)
a series of 43 photographs of lesions for which a histologic diag-
nosis also was available by the time this component was con-
ducted. This included a mixture of benign and neoplastic
pathologies. They were asked to independently write down their
diagnosis and whether they thought it was benign or malignant.
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Data Analysis
Data were entered into Access 2007 (Microsoft Corp., Redmond,
WA) and analyzed using Stata 11.0 (StataCorp LP, College
Station, TX). Demographic characteristics of cases and controls
were compared by conditional logistic regression. For the purpose
of analysis, occupation was condensed to “indoors” or “outdoors”
and region of residence to “Kilimanjaro region” and “outside
Kilimanjaro region.” The Wilcoxon rank-sum test was used to
compare the ages between cases and control because the distribu-
tion was skewed. The frequency of clinical signs and symptoms in
benign and neoplastic lesions was compared using the Fisher exact
test.
The Kappa statistic was used to assess the agreement between
the categorized tissue diagnosis (benign or OSSN), and clinical
diagnosis made from photographs by the 8 ophthalmologists
(benign or OSSN). To calculate an average value, the kappa
statistics for each grader were transformed to Z scores using the
Fisher Z transformation, averaged, and then back-transformed to
a kappa statistic. The clinical and IVCM features were analyzed in
relation to the histologic diagnosis. Associations between the tissue
diagnosis and the presence of speciﬁc clinical or IVCM features
were assessed by the Fisher exact test. Agreement between the
categorized tissue diagnosis (normal, benign, or malignant) and the
masked IVCM grading (normal, benign, or malignant) was
assessed by a weighted Kappa statistic.
Results
Study Participants
Sixty individuals with conjunctiva lesions (cases) and 60 age-
matched controls with healthy ocular surfaces were recruited.
The cases and controls had comparable demographic proﬁles: age,
sex, region of origin, and occupational history (Table 1).
Diagnoses
Five cases declined surgical excision of their lesions, and a further
3 cases had surgical excision without histopathology, leaving 52 of
60 cases with a histologic diagnosis (Table 1). For 34 cases, the
histologic diagnosis was on the OSSN spectrum, 17 had benign
lesions, and 1 case had lymphoma. Of the 8 cases without
Figure 2. In vivo confocal microscopy images of conjunctival ocular surface squamous neoplasia. A, Small hyper-reﬂective cells. B, Large hyper-reﬂective
cells of variable size. C, Possible mitotic ﬁgure (arrow) and prominent basal cell nucleoli. D, Amorphous, possibly keratinized material. Scale bar 50 mm.
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histology, the clinical diagnosis was OSSN in 6, pterygium in 1,
and pingeculum in 1. Biopsy tissue was not collected from
control participants with clinically normal conjunctiva. The most
common clinical diagnoses of controls were normal examination
results, diabetic retinopathy, and cataract (Table 1).
Symptoms and Signs
Among individuals with conjunctival lesions, there was no
difference in the frequency of various symptoms between benign
and OSSN cases (Table 2). However, OSSN cases had a shorter
time to presentation, suggesting a more symptomatic or rapidly
evolving lesion (3.7 vs. 8.8 months; P ¼ 0.03). Several clinical
signs were more frequently found in eyes with OSSN (with
borderline statistical signiﬁcance): feeder vessel, leukoplakia, and
gelatinous appearance (Fig 1, Table 2). A ﬁbrovascular
appearance was more frequent among benign lesions. The OSSN
lesions tended to be larger than benign lesions, although this
difference was not signiﬁcant (Wilcoxon rank-sum P ¼ 0.8).
Human Immunodeﬁciency Virus and Conjunctival
Lesions
Among the 52 cases (benign and OSSN) with a tissue diagnosis,
there was a strong association between HIV and OSSN (58.8%)
compared with benign cases (5.6%) (odds ratio, 24.3; 95% conﬁ-
dence interval [CI], 2.8e204; P ¼ 0.003) (Table 3). Human
immunodeﬁciency virus infection also tended to be more frequent
in people with SCC compared with CIN (68.4% vs. 46.7%;P¼ 0.2).
Reliability of the Clinical Diagnosis
Eight ophthalmologists were shown a consecutive series of 43
images of conjunctival lesions and asked to classify them into 2
broad categories of benign and neoplastic. Their diagnoses were
compared with the histopathology results, and kappa statistics were
calculated: average kappa statistic 0.51 (95% CI, 0.36e0.64). Two
ophthalmologists had “fair” agreement (kappas of 0.21 and 0.40), 3
ophthalmologists had “moderate” agreement (0.41e0.60), and 3
ophthalmologists had “substantial” agreement (0.61e0.80). The
correct diagnosis was made in 56% to 86% of the cases.
In Vivo Confocal Microscopy
In vivo confocal microscopy was attempted on all 120 cases and
controls, and the scans were graded in a masked manner. Three
controls were excluded because of inadequate IVCM images.
Histopathology results were available for 52 of 60 cases. The
archived IVCM images from 8 of 52 of the cases were not of
Table 2. Symptoms and Clinical Signs by Histologic Diagnosis
OSSN Cases Benign Cases* P Valuey
Symptom
Irritated red eye 21 (61.7%) 8 (44.4%) 0.26
Discharge 20 (58.8%) 11 (61.1%) 1.00
Foreign body sensation 14 (41.1%) 10 (55.5%) 0.39
Decreased vision 8 (23.5%) 3 (16.6%) 0.73
Pain 5 (14.7%) 5 (27.7%) 0.29
Proptosis 5 (14.7%) 1 (5.5%) 0.65
Itchy 2 (5.8%) 1 (5.5%) 1.00
Mean duration
(mos, 95% CI)
3.7 (2.4e5.8) 8.8 (3.9e19) 0.029
Sign
Feeder vessel 30 (88.2%) 11 (61.1%) 0.034
Limbal involvement 26 (76.4%) 9 (50.0%) 0.07
Leukoplakia 15 (44.1%) 3 (16.6%) 0.07
Gelatinous 13 (38.2%) 2 (11.1%) 0.055
Pedunculated 4 (11.7%) 2 (11.1%) 1.00
Papilliform 2 (5.8%) 1 (5.5%) 1.00
Orbital invasion 2 (5.8%) 0 (0.0%) 0.54
Fibrovascular tissue 1 (2.9%) 7 (44.4%) 0.001
CI ¼ conﬁdence interval; OSSN ¼ ocular surface squamous neoplasia.
*Including 1 lymphoma case.
yP values calculated using Fisher exact test for variables except duration,
which was calculated by Wilcoxon rank-sum test.
Table 1. Demographic Characteristics and Diagnoses of Study
Participants
Characteristics
Cases Controls
Total P Value*N ¼ 60 N ¼ 60
Female 30 (50%) 36 (60%) 66 (55%) 0.28
Region (Kilimanjaro) 35 (58.3%) 39 (65.0%) 74 (61.6%) 0.45
Occupation (outdoor) 35 (58.3%) 30 (50.0%) 65 (54.1%) 0.34
Age (yrs)
Mean 43.5 43.7 43.6 0.95
Range 23e80 21e75 21e80
Histologic diagnosis
CIN I 2 (3.3%) e e
CIN II 3 (5.0%) e e
CIN III 5 (8.3%) e e
CIS 5 (8.3%) e e
SCC I 12 (20.0%) e e
SCC II 4 (6.6%) e e
SCC III 3 (5.0%) e e
Lymphoma 1 (1.6%) e e
Pterygium 5 (8.3%) e e
Pingueculum 3 (5.0%) e e
Papilloma 3 (5.0%) e e
Other benign lesions 6 (10.0%) e e
No histopathology 8 (13.3%) e e
Control diagnosis
Normal examination e 26 (43.3%) e
Diabetic retinopathy e 10 (16.6%) e
Cataract e 9 (15.0%) e
Glaucoma e 3 (5.0%) e
Astigmatism e 6 (10.0%) e
Hyperopia e 1 (1.6%) e
Presbyopia e 3 (5.0%) e
Optic atrophy e 1 (1.6%) e
Myopia e 1 (1.6%) e
CIN ¼ conjunctiva intra-epithelial neoplasia; CIS ¼ carcinoma in situ;
SCC ¼ squamous cell carcinoma.
*P value from conditional logistic regression for sex, region, and occupation
and from Wilcoxon rank-sum test for age.
Table 3. Human Immunodeﬁciency Virus Test Results by Tissue
Diagnosis of Conjunctival Lesions
Tissue Diagnosis HIV Positive OR 95% CI P Value
Benign lesions* 1/18 (5.6%) 1 e e
CIN 7/15 (46.7%) 14.9 1.56e142 0.019
SCC 13/19 (68.4%) 36.8 3.93e344 0.002
CI ¼ conﬁdence interval; CIN ¼ conjunctiva intra-epithelial neoplasia;
HIV ¼ human immunodeﬁciency virus; OR ¼ odds ratio; SCC ¼ squa-
mous cell carcinoma.
*Including 1 lymphoma case.
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sufﬁcient quality for masked grading. Therefore, the analysis of
IVCM was limited to 101 participants: 44 cases (with both histo-
pathology and adequate scans) and 57 controls.
The IVCM images were examined for the presence of speciﬁc
features: hyper-reﬂective cells, variation of cell size, mitotic cells,
and “starry night” appearance of the basal layer (Fig 2, Table 4).
Several lesions showed marked surface changes on IVCM with
extensive, hyper-reﬂective material with large irregular cellular
structure. A possible mitotic cell was observed in only 1 lesion (Fig
2C). Among the 57 controls with IVCM images, 3 had some
hyper-reﬂective cells and 2 showed some variation in epithelial
cell size. For each of the graded features, there were statistically
signiﬁcant differences in their frequency between the normal
controls and cases (benign and malignant combined). However, we
found no evidence for a difference in the frequency of these IVCM
features between benign and malignant conjunctival lesions.
Each set of IVCM images was given an overall classiﬁcation by
the masked readers: normal, benign abnormal, or malignant. The
comparison of this overall IVCM classiﬁcation with the histopa-
thology diagnosis is shown in Table 5. Agreement was found to be
moderate with an unweighted kappa score of 0.44 (95% CI,
0.32e0.57). The linear weighted kappa score was 0.54 (95% CI,
0.40e0.67). The sensitivity and speciﬁcity of IVCM for
distinguishing OSSN from benign conjunctival lesions were 38.5%
(95% CI, 0.21e0.59) and 66.7% (95% CI, 0.41e0.86), respectively.
Discussion
Timely detection and treatment of OSSN are challenges in
East Africa, with many patients only presenting when the
lesion is already established. The reasons for this are many:
Access to eye care services outside the major urban centers
is generally limited; therefore, patients may delay traveling
for treatment until the lesion is more obvious and symp-
tomatic. When patients do present, there can be further delay
in making the diagnosis of OSSN because initially it may be
thought to be a benign lesion. Delayed or missed diagnosis
can have considerable effects on ocular morbidity and even
mortality.
In this study based in an East African ophthalmic referral
center, OSSN was a common cause of conjunctival
pathology, with presentation rates comparable to those in
previous reports from this unit.3,4 Time between onset of
symptoms and presentation was shorter for OSSN than for
benign lesions, possibly because OSSN develops more
rapidly. However, some individuals with OSSN had noticed
a problem many months earlier. Strategies are needed to
raise general awareness that growths on the eye need prompt
attention. This is particularly important in people who have
a known diagnosis of HIV, but this needs to be done in
a way that minimizes stigma.
There is an overlap in the clinical signs of (early) OSSN
and some benign lesions (Fig 1A, B). However, a number of
features tended to be more frequent in cases of OSSN:
feeder vessels, gelatinous appearance, and leukoplakia.
These and other signs could form the basis of a diagnostic
algorithm to assist the clinician in identifying OSSN
cases, and they warrant further study in a larger data set.
Overall, the 8 ophthalmologists, most of whom had seen
many cases of OSSN previously, achieved only moderate
agreement with the histologic diagnosis. There was a wide
range in their diagnostic accuracy, suggesting that if the
key features that point to a diagnosis of OSSN can be
identiﬁed and emphasized in training, there should be
scope to improve the detection rate.
The prevalence of HIV infection in OSSN cases was
comparable to that in previous studies from the region.4
Human immunodeﬁciency virus seems to be a risk factor
for developing more severe disease, being more frequent
among cases with SCC than CIN. There was no difference
in the time between the onset of symptoms and the
presentation between SCC and CIN, suggesting that HIV
infection permits a more rapid progression in the disease.
In vivo confocal microscopy is a potentially useful tool in
the management of several external eye diseases. It has been
particularly helpful in the diagnosis of acanthamoeba and
ﬁlamentary fungal keratitis.18 We have also found the
technique informative in the study of conjunctival scarring
Table 4. In Vivo Confocal Microscopy Features by Disease Group,
Based on Masked Grading
IVCM Features
Controls
Benign
Cases*
OSSN
Cases P
Valuey
P
ValuezN/57 (%) N/18 (%) N/26 (%)
Hyper-reﬂective
cells
<0.001 0.9
None 54 (94.7%) 7 (38.3%) 12 (46.1%)
<50% 3 (5.3%) 7 (38.8%) 8 (30.7%)
>50% 0 (0.0%) 4 (22.2%) 6 (23.1%)
Variation in cell
size
<0.001 0.5
Uniform 55 (96.4%) 9 (50%) 17 (65.3%)
Mild 1 (1.7%) 6 (33.3%) 4 (15.3%)
Marked 1 (1.7%) 3 (16.7%) 5 (19.2%)
Starry night
appearance of
basal cells
0.001 0.8
Nil 57 (100%) 14 (77.7%) 22 (84.6%)
Few to many 0 (0.0%) 2 (11.1%) 1 (3.8%)
Amorphous
material
0 (0.0%) 2 (11.1%) 3 (11.5%)
IVCM ¼ in vivo confocal microscopy; OSSN ¼ ocular surface squamous
neoplasia.
*Including 1 lymphoma case.
yP value is for the comparison of normal controls with all cases (benign and
malignant combined) by Fisher exact test.
zP value is for the comparison of benign with malignant cases, by Fisher
exact test.
Table 5. Comparison of the Overall Classiﬁcation from the
In Vivo Confocal Microscopy Based on Masked Grading (Normal,
Benign, or Malignant) versus the Final Histologic Diagnosis
Tissue Diagnosis
IVCM Diagnosis
TotalNormal Abnormal Benign Malignant
Normal control 50 7 0 57
Benign lesion 4 8 6 18
Malignant lesion 5 11 10 26
Total 59 26 16 101
IVCM ¼ in vivo confocal microscopy.
Grey shading highlights where there was agreement.
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in trachoma.19 In the present study, masked analysis of
IVCM clearly distinguished between normal conjunctiva
and lesions (benign or malignant). A few clinically normal
controls had some minor changes on IVCM, which might
be attributable to solar radiation damage. In contrast, it
was not possible to reliably distinguish between OSSN
and benign conjunctival lesions because there seems to be
an overlap in the IVCM features of these various
conditions. We did not identify any features that were
exclusive to OSSN. Of particular note was the ﬁnding that
there were several cases of OSSN that were classiﬁed as
normal on IVCM.
Our conclusion that IVCM does not reliably distinguish
OSSN from other conjunctival pathology contrasts with
earlier reports that suggest it may be possible to use it for
this purpose.12e16 However, these earlier reports, mostly
from Europe (where the disease spectrum is different), have
tended to be of relatively few cases. Moreover, with the
exception of 1 series of 4 cases, benign lesion controls have
not been recruited for comparison. Finally, the assessment
of the images was not masked in all but 1 of the previous
studies.16 Without systematic masked comparison with
benign lesions, it is difﬁcult to know how useful the
observed features are. Studies of the IVCM appearance of
pterygium have reported hyper-reﬂective epithelial cells,
a feature previously said to be associated with OSSN.20,21
This is the ﬁrst time IVCM has been used in Africa to
study OSSN. Overall, the disease tends to be more advanced
and aggressive in this context, and clinical/IVCM features
may show signiﬁcant variation from studies of Caucasian
patients with disease largely unassociated with HIV. Further
validation is needed using masked grading of OSSN and
other conjunctival pathology in other settings.
Study Limitations
First, histopathology was not available for all conjunctival
lesions because the patient declined surgery or the surgeon
did not send a sample for analysis. Second, it was not
always possible to obtain IVCM scans of sufﬁcient quality
for the masked grading, usually because the patient was
unable to tolerate the examination. Third, the masked
analysis was limited to the set of stored volume scans; in
practice, the formation of a diagnostic impression with
IVCM is based on a continuous, dynamic examination in
which the examiner is not masked to the clinical appearance
of the eye. A limitation of current IVCM technology is that
it is not possible to identify exactly where on the lesion the
scan is collected from; therefore, it is not possible to put it in
exact correspondence with ﬁndings from histopathology.
Finally, the conclusions of this study may not be general-
izable to the use of IVCM to detect OSSN in other settings if
the distribution of disease stage is different.
In conclusion, ocular surface squamous neoplasia
remains a major clinical challenge in the East African
context. A simple and cheap diagnostic test to help distin-
guish benign from malignant pathology would be of
considerable utility in the East African context, where
pathology services may not be readily available.
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